Next Article in Journal
Agreement between In-Clinics and Virus Neutralization Tests in Detecting Antibodies against Canine Distemper Virus (CDV)
Next Article in Special Issue
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
Previous Article in Journal
Multiorgan and Vascular Tropism of SARS-CoV-2
Previous Article in Special Issue
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort
 
 
Review

Article Versions Notes

Viruses 2022, 14(3), 516; https://doi.org/10.3390/v14030516
Action Date Notes Link
article xml file uploaded 3 March 2022 08:23 CET Original file -
article xml uploaded. 3 March 2022 08:23 CET Update https://www.mdpi.com/1999-4915/14/3/516/xml
article pdf uploaded. 3 March 2022 08:23 CET Version of Record https://www.mdpi.com/1999-4915/14/3/516/pdf
article html file updated 3 March 2022 08:24 CET Original file -
article html file updated 1 August 2022 03:50 CEST Update https://www.mdpi.com/1999-4915/14/3/516/html
Back to TopTop